NCT02128711View on ClinicalTrials.gov

Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

November 22, 2024

Study Completion Date

July 31, 2025

Conditions

Cystic Fibrosis

Trial Locations (1)

55455

University of Minnesota Medical School, Minneapolis

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Minnesota

OTHER

NCT02128711 - Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens | Biotech Hunter | Biotech Hunter